USA - July 29 2016
CRISPR is a gene editing technique that promises to revolutionize genetic engineering, but already is raising ethical, business, and legal issues…
Simon J. Elliott, Stephen B. Maebius
USA - July 29 2016
This is the first update on CRISPR, following on from our June 24 web conference entitled, "Navigating the CRISPR Patent Landscape and Business…
Simon J. Elliott
USA - July 7 2016
The Chinese government has been in the process of modernizing its telemedicine law and policy and associated infrastructure for nearly 2 years now…
Richard J. Ferris, Jr.
USA - May 31 2016
Many patent owners have not yet had to defend against an inter partes review (IPR), but the popularity of this proceeding increases the chances that…
Jason N. Mock, Kiri Lee Sharon
China, USA - December 3 2015
Telemedicine continues to attract international attention, with China on track to become one of the largest telemedicine markets in the world. Just a…
Richard J. Ferris, Jr., Nathaniel M. Lacktman